Filing Flows

Filing Flows › 8-K events › Clover Health Investments

Clover Health Investments: results of operations

Form 8-K filed Nov 4, 2026 · items 2.02, 5.02

CFO changesClover Health Reports Third Quarter 2026 Results

What the filing says

• Strong third quarter performance brings year-to-date GAAP Net Income to $62 million alongside 49% year-over-year Medicare Advantage membership growth • Improved Full Year 2026 guidance across all metrics

ScaleThe filing names $62.0M: about 2% of Clover Health Investments' annual revenue ($3.04B, four times the latest quarter).

Read the filing on SEC EDGAR →

What usually followsAcross 69,115 8-Ks reporting Item 2.02 (results of operations) in our universe, the stock's median move the next session was +0.2% (typical size ±3.6%, up 51% of the time); over the following 21 sessions, +1.2%. Item 5.02: −0.1% next session across 39,174. Every item ranked →

What this kind of filing means

Item 5.02 — Departure or appointment of directors and officers. Leadership changes: who leaves, who arrives and on what terms. A sudden CEO or CFO departure without a successor deserves attention.

Clover Health Investments at a glance

Latest quarterQ3 2026
Revenue$759.3M
Revenue Y/Y+53%
Operating margin0.8%
IndustryHospital & Medical Service Plans

Clover Health Investments, Q3 2026: revenue $759M (+53% year over year), operating margin 0.8%. The chart follows the revenue to costs, profit and cash.

Clover Health Investments: every quarter, Q/Q and Y/Y, holders and guidance →

Other recent cfo changes

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.